Reproduction permitted for personal use only. For reprints and reprint permission, contact

Promega and EraGen sign technology licensing agreement

Madison, Wis. -- Promega Corporation and EraGen Biosciences, two Madison-based life science companies, signed a licensing agreement Wednesday allowing Promega to develop products using EraGen’s research assays. The partnership also grants Promega global distribution rights for research assays.

“Promega should expect rapid market acceptance as validated by our recent SARS detection system. A market presence by Promega will further enhance EraGen’s product development for the clinical diagnostic market,” said Irene Hrusovsky, president and chief of operations of EraGen.

EraGen will provide its chemistry and software to analyze test results. Promega will develop and manufacture reagent systems in its Madison facility with the first branded product scheduled to be launched this year.

EraGen develops and commercializes molecular diagnostics. Promega provides technical support to the life sciences industry by combining chemistry and software.

-Add Your Comment


Comment Policy: WTN News accepts comments that are on-topic and do not contain advertisements, profanity or personal attacks. Comments represent the views of the individuals who post them and do not necessarily represent the views of WTN Media or our partners, advertisers, or sources. Comments are moderated and are not immediately posted. Your email address will not be posted.

WTN Media cannot accept liability for the content of comments posted here or verify their accuracy. If you believe this comment section is being abused, contact

WTN Media Presents